What shifts have been observed by Oncologists in the treatment of Neutropenia? (Oncologist 2)
MMIT’s P&T Persectives on Neutropenia reviewed Rolontis® (eflapegrastim), a new long-acting rhG-CSF therapy for patients with chemotherapy induced neutropenia.
© 2025 MMIT